Identification of novel formyl peptide receptor-like 1 agonists that induce macrophage tumor necrosis factor α production

Molecular Pharmacology

Volumn 74, Issue 2, 2008, Pages 392-402

  Schepetkin, Igor A ^a   Kirpotina, Liliya N ^a   Tian, Jun ^b   Khlebnikov, Andrei I ^c   Ye, Richard D ^b   Quinn, Mark T ^a  

^a MONTANA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c ALTAI STATE TECHNICAL UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

4 FLUORO BENZOIC ACID[5 (3 TRIFLUOROMETHYL PHENYL) 2 FURYL]METHYLENE HYDRAZIDE]; AG 1; AG 14; AG 15; AG 8; CALCIUM; FORMYLPEPTIDE RECEPTOR LIKE 1; HYDRAZIDE DERIVATIVE; LIGAND; N T BUTOXYCARBONYL PHENYLALANYLLEUCYLPHENYLALANYLLEUCYLPHENYLALANINE; NICOTINIC ACID [5 (3 BROMOPHENYL) 2 FURYL]METHYLENE HYDRAZIDE; PERTUSSIS TOXIN; REACTIVE OXYGEN METABOLITE; TRYPTOPHYLARGINYLTRYPTOPHYLTRYPTOPHYLTRYPTOPHYLTRYPTOPHYL CARBON MONOXIDE AMIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL LINE; CHEMOTAXIS; CONFORMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; ENERGY; HUMAN; HUMAN CELL; MACROPHAGE; MODEL; MONOCYTE; MOUSE; NONHUMAN; PHAGOCYTE; PHARMACOPHORE; PRIORITY JOURNAL; RAT; SCREENING;

ANIMALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MACROPHAGES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; PHARMACEUTICAL PREPARATIONS; RATS; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 47949115987     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.108.046946     Document Type: Article

References (35)

1. Almasirad A, Hosseini R, Jalalizadeh H, Rahimi-Moghaddam Z, Abaeian N, Janafrooz M, Abbaspour M, Ziaee V, Dalvandi A, and Shafiee A (2006) Synthesis and analgesic activity of 2-phenoxybenzoic acid and N-phenylanthranilic acid hydrazides. Biol Pharm Bull 29:1180-1185.
2. Bae YS, Lee HY, Jo EJ, Kim JI, Kang HK, Ye RD, Kwak JY, and Ryu SH (2004) Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling. J Immunol 173:607-614.
3. Baguley BC (2001) Small-molecule cytokine inducers causing tumor necrosis. Curr Opin Investig Drugs 2:967-975.
4. Bertsch U, Winklhofer KF, Hirschberger T, Bieschke J, Weber P, Hartl FU, Tavan P, Tatzelt J, Kretzschmar HA, and Giese A (2005) Systematic identification of antiprion drugs by high-throughput screening based on scanning for intensely fluorescent targets. J Virol 79:7785-7791.
5. Beutler B (1995) TNF, immunity and inflammatory disease: lessons of the past decade. J Investig Med 43:227-235.
6. Boykin DW Jr. and Varma RS (1970) Benzylidene hydrazides as potential anticancer agents. J Med Chem 13:583-584.
7. Burkhart CA, Berman JW, Swindell CS, and Horwitz SB (1994) Relationship between the structure of taxol and other taxanes on induction of tumor necrosis factor-alpha gene expression and cytotoxicity. Cancer Res 54:5779-5782.
8. Byrd-Leifer CA, Block EF, Takeda K, Akira S, and Ding A (2001) The role of MyD88 and TLR4 in the LPS-mimetic activity of Taxol. Eur J Immunol 31:2448-2457.
9. Edwards BS, Bologa C, Young SM, Balakin KV, Prossnitz ER, Savchuck NP, Sklar LA, and Oprea TI (2005) Integration of virtual screening with high-throughput flow cytometry to identify novel small molecule formylpeptide receptor antagonists. Mol Pharmacol 68:1301-1310.
10. Engelhardt R, Mackensen A, and Galanos C (1991) Phase I trial of intravenously administered endotoxin (Salmonella abortus equi) in cancer patients. Cancer Res 51:2524-2530.
11. Gao JL, Chen H, Filie JD, Kozak CA, and Murphy PM (1998) Differential expansion of the N-formylpeptide receptor gene cluster in human and mouse. Genomics 51:270-276.
12. Gavins FN, Yona S, Kamal AM, Flower RJ, and Perretti M (2003) Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms. Blood 101:4140-4147.
13. Gordon S (2007) The macrophage: past, present and future. Eur J Immunol 37 (Suppl 1):S9-S17.
14. Guner O, Clement O, and Kurogi Y (2004) Pharmacophore modeling and three dimensional database searching for drug design using catalyst: recent advances. Curr Med Chem 11:2991-3005.
15. Hu J, Li G, TongY, Li Y, Zhou G, HeX, Xie P, Wang JM, and Sun Q (2005) Transduction of the gene coding for a human G-protein coupled receptor FPRL1 in mouse tumor cells increases host anti-tumor immunity. Int Immunopharmacol 5:971-980.
16. Huang J, Hu J, Bian X, Chen K, Gong W, Dunlop NM, Howard OM, and Wang JM (2007) Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behavior of human glioblastoma cells. Cancer Res 67:5906-5913.
17. Kelher MR, Ambruso DR, Elzi DJ, Anderson SM, Paterson AJ, Thurman GW, and Silliman CC (2003) Formyl-met-leu-phe induces calcium-dependent tyrosine phosphorylation of rel-1 in neutrophils. Cell Calcium 34:445-455.
18. Le Y, Hu J, Gong W, Shen W, Li B, Dunlop NM, Halverson DO, Blair DG, and Wang JM (2000) Expression of functional formyl peptide receptors by human astrocytoma cell lines. J Neuroimmunol 111:102-108.
19. Lejeune FJ, Lienard D, Matter M, and Ruegg C (2006) Efficiency of recombinant human TNF in human cancer therapy. Cancer Immun 6:6.
20. Migeotte I, Communi D, and Parmentier M (2006) Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses. Cytokine Growth Factor Rev 17:501-519.
21. Nanamori M, Cheng X, Mei J, Sang H, Xuan Y, Zhou C, Wang MW, and Ye RD (2004) A novel nonpeptide ligand for formyl peptide receptor-like 1. Mol Pharmacol 66:1213-1222.
22. Nicklaus MC, Wang SM, Driscoll JS, and Milne GWA (1995) Conformational changes of small molecules binding to proteins. Bioorg Med Chem 3:411-428.
23. Perretti M, Chiang N, La M, Fierro IM, Marullo S, Getting SJ, Solito E, and Serhan CN (2002) Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 Receptor. Nat Med 8:1296-1302.
24. Reed JC (2006) Drug insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms. Nat Clin Pract Oncol 3:388-398.
25. Rescher U, Danielczyk A, Markoff A, and Gerke V(2002) Functional activation of the formyl peptide receptor by a new endogenous ligand in human lung A549 cells. J Immunol 169:1500-1504.
26. Schepetkin IA, Kirpotina LN, Khlebnikov AI, and Quinn MT (2007) High-throughput screening for small-molecule activators of neutrophils: identification of novel N-formyl peptide receptor agonists. Mol Pharmacol 71:1061-1074.
27. Schön M and Schön MP (2007) The antitumoral mode of action of imiquimod and other imidazoquinolines. Curr Med Chem 14:681-687.
28. Serhan CN (2007) Resolution phase of inflammation: novel endogenous antiinflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol 25:101-137.
29. Simunek T, Boer C, Bouwman RA, Vlasblom R, Versteilen AM, Sterba M, Gersl V, Hrdina R, Ponka P, de Lange JJ, et al. (2005) SIH-a novel lipophilic iron chelator-protects H9c2 cardiomyoblasts from oxidative stress-induced mitochondrial injury and cell death. J Mol Cell Cardiol 39:345-354.
30. Tosi MF (2005) Innate immune responses to infection. J Allergy Clin Immunol 116:241-249.
31. Vulcano M, Rosa MFA, Minnucci FS, Cherñavsky AC, and Isturiz MA (1998) N-Formyl-methionyl-leucyl-phenylalanine (FMLP) inhibits tumour necrosis factor-alpha (TNF-α) production on lipopolysaccharide (LPS)-stimulated human neutrophils. Clin Exp Immunol 113:39-47.
32. Watanabe N, Suzuki J, and Kobayashi Y (1996) Role of calcium in tumor necrosis factor-α production by activated macrophages. J Biochem 120:1190-1195.
33. Zhang HZ, Drewe J, Tseng B, Kasibhatla S, and Cai SX (2004) Discovery and SAR of indole-2-carboxylic acid benzylidene-hydrazides as a new series of potent apoptosis inducers using a cell-based HTS assay. Bioorg Med Chem 12:3649-3655.
34. Zhang X and Morrison DC (1993) Pertussis toxin-sensitive factor differentially regulates lipopolysaccharide-induced tumor necrosis factor-α and nitric oxide production in mouse peritoneal macrophages. J Immunol 150:1011-1018.
35. Zhou Y, Bian X, Le Y, Gong W, Hu J, Zhang X, Wang L, Iribarren P, Salcedo R, Howard OM, et al. (2005) Formylpeptide receptor FPR and the rapid growth of malignant human gliomas. J Natl Cancer Inst 97:823-835.